Live symbol workspace

JNJ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $243.04

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$230.89

Resistance

$255.19

Volume & Momentum

Volume

Normal

1.0x avg

Momentum

0%

Weak

Technical Context

Current price

$243.04

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for JNJ skewed bullish (3 of 4 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

▼ 1.7 pts vs previous week

Avg confidence across 21 calls in the last 7 days

What sources say

Bullish 3 articles

JPMorgan says this S&P 500 sector "offers a rare combination of durable growth"

Hedge Fund Healthcare Bets Approach Five-Year High

Johnson & Johnson Now Leads Its Pitch With An Oncology Bet

Neutral 1 article

JNJ Keeps Climbing. Should You Climb On?

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

JNJ News Intelligence (31 articles)

AI-curated news influencing JNJ price, sentiment, and trend

Explore All JNJ News with AI Analysis

Economy

1 week, 5 days ago

JNJ Keeps Climbing. Should You Climb On?

This healthcare giant is on a serious run, but with the stock trading at a peak, investors must decide if …

Impact on JNJ: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

3 weeks, 6 days ago

JPMorgan says this S&P 500 sector "offers a rare combination of durable growth"

Investing.com -- JPMorgan reiterated a favorable view on the healthcare sector in a note Tuesday, calling the risk/reward attractive after …

Impact on JNJ: The JPMorgan note may lead to a positive price reflection in healthcare …

JPMorgan has reiterated its favorable view on the S&P 500 healthcare sector, citing an attractive … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

3 weeks, 6 days ago

Hedge Fund Healthcare Bets Approach Five-Year High

Specialist funds returned nearly 40% as AI drug discovery and deal activity attracted additional capital.

Impact on JNJ: The increased investment in healthcare is expected to positively impact healthcare stocks, …

Hedge fund investments in the healthcare sector have reached a nearly five-year high, driven by … High (80%)

View full analysis →

Yahoo Finance 80% confidence

Economy

4 weeks ago

Johnson & Johnson Now Leads Its Pitch With An Oncology Bet

The company that used to reassure you with its sheer breadth now leads with a push to dominate oncology, and …

Impact on JNJ: Johnson & Johnson's (JNJ) increased focus on oncology may lead to a …

Johnson & Johnson is shifting its focus towards dominating the oncology sector, which may impact … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy ⭐ FEATURED

4 weeks, 2 days ago

Nasdaq lags on angst over AI spending ahead of earnings reports

STORY: U.S. stocks ended mixed on Friday, with the Dow gaining just under half a percent, the S&P 500 virtually …

Impact on JNJ: The Nasdaq's decline, led by a nearly 8% drop in Intel despite …

The Nasdaq lagged behind other US indexes due to concerns over AI spending, while the … High (80%)

View full analysis →

Yahoo Finance 80% confidence

Economy

1 month, 1 week ago

Is Johnson & Johnson a Buy After Its Latest Earnings Report?

Investors didn't seem to think so after the company published it.

Impact on JNJ: The lack of enthusiasm from investors following Johnson & Johnson's earnings report …

Johnson & Johnson's latest earnings report failed to impress investors, leading to a negative market … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence